Global COVID-19 Diagnosis Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 183441
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Technology
Buy @ $3500

The COVID-19 Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global COVID-19 Diagnosis size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global COVID-19 Diagnosis market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

COVID-19 Diagnosis market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

RT-PCR

Isothermal Nucleic Acid Amplification

Others

Market segment by Application, can be divided into

Hospital

Laboratory

Market segment by players, this report covers

Cepheid

Abbott

Mesa Biotech

Microsens Dx

GenMark Diagnostics

Credo

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of COVID-19 Diagnosis

1.2 Classification of COVID-19 Diagnosis by Type

1.2.1 Overview: Global COVID-19 Diagnosis Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global COVID-19 Diagnosis Revenue Market Share by Type in 2020

1.2.3 RT-PCR

1.2.4 Isothermal Nucleic Acid Amplification

1.2.5 Others

1.3 Global COVID-19 Diagnosis Market by Application

1.3.1 Overview: Global COVID-19 Diagnosis Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Laboratory

1.4 Global COVID-19 Diagnosis Market Size & Forecast

1.5 Global COVID-19 Diagnosis Market Size and Forecast by Region

1.5.1 Global COVID-19 Diagnosis Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global COVID-19 Diagnosis Market Size by Region, (2016-2021)

1.5.3 North America COVID-19 Diagnosis Market Size and Prospect (2016-2026)

1.5.4 Europe COVID-19 Diagnosis Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific COVID-19 Diagnosis Market Size and Prospect (2016-2026)

1.5.6 South America COVID-19 Diagnosis Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa COVID-19 Diagnosis Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 COVID-19 Diagnosis Market Drivers

1.6.2 COVID-19 Diagnosis Market Restraints

1.6.3 COVID-19 Diagnosis Trends Analysis

2 Company Profiles

2.1 Cepheid

2.1.1 Cepheid Details

2.1.2 Cepheid Major Business

2.1.3 Cepheid COVID-19 Diagnosis Product and Solutions

2.1.4 Cepheid COVID-19 Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Cepheid Recent Developments and Future Plans

2.2 Abbott

2.2.1 Abbott Details

2.2.2 Abbott Major Business

2.2.3 Abbott COVID-19 Diagnosis Product and Solutions

2.2.4 Abbott COVID-19 Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Abbott Recent Developments and Future Plans

2.3 Mesa Biotech

2.3.1 Mesa Biotech Details

2.3.2 Mesa Biotech Major Business

2.3.3 Mesa Biotech COVID-19 Diagnosis Product and Solutions

2.3.4 Mesa Biotech COVID-19 Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Mesa Biotech Recent Developments and Future Plans

2.4 Microsens Dx

2.4.1 Microsens Dx Details

2.4.2 Microsens Dx Major Business

2.4.3 Microsens Dx COVID-19 Diagnosis Product and Solutions

2.4.4 Microsens Dx COVID-19 Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Microsens Dx Recent Developments and Future Plans

2.5 GenMark Diagnostics

2.5.1 GenMark Diagnostics Details

2.5.2 GenMark Diagnostics Major Business

2.5.3 GenMark Diagnostics COVID-19 Diagnosis Product and Solutions

2.5.4 GenMark Diagnostics COVID-19 Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 GenMark Diagnostics Recent Developments and Future Plans

2.6 Credo

2.6.1 Credo Details

2.6.2 Credo Major Business

2.6.3 Credo COVID-19 Diagnosis Product and Solutions

2.6.4 Credo COVID-19 Diagnosis Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Credo Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global COVID-19 Diagnosis Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 COVID-19 Diagnosis Players Market Share

3.2.2 Top 10 COVID-19 Diagnosis Players Market Share

3.2.3 Market Competition Trend

3.3 COVID-19 Diagnosis Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global COVID-19 Diagnosis Revenue and Market Share by Type (2016-2021)

4.2 Global COVID-19 Diagnosis Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global COVID-19 Diagnosis Revenue Market Share by Application (2016-2021)

5.2 COVID-19 Diagnosis Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America COVID-19 Diagnosis Revenue by Type (2016-2026)

6.2 North America COVID-19 Diagnosis Revenue by Application (2016-2026)

6.3 North America COVID-19 Diagnosis Market Size by Country

6.3.1 North America COVID-19 Diagnosis Revenue by Country (2016-2026)

6.3.2 United States COVID-19 Diagnosis Market Size and Forecast (2016-2026)

6.3.3 Canada COVID-19 Diagnosis Market Size and Forecast (2016-2026)

6.3.4 Mexico COVID-19 Diagnosis Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe COVID-19 Diagnosis Revenue by Type (2016-2026)

7.2 Europe COVID-19 Diagnosis Revenue by Application (2016-2026)

7.3 Europe COVID-19 Diagnosis Market Size by Country

7.3.1 Europe COVID-19 Diagnosis Revenue by Country (2016-2026)

7.3.2 Germany COVID-19 Diagnosis Market Size and Forecast (2016-2026)

7.3.3 France COVID-19 Diagnosis Market Size and Forecast (2016-2026)

7.3.4 United Kingdom COVID-19 Diagnosis Market Size and Forecast (2016-2026)

7.3.5 Russia COVID-19 Diagnosis Market Size and Forecast (2016-2026)

7.3.6 Italy COVID-19 Diagnosis Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific COVID-19 Diagnosis Revenue by Type (2016-2026)

8.2 Asia-Pacific COVID-19 Diagnosis Revenue by Application (2016-2026)

8.3 Asia-Pacific COVID-19 Diagnosis Market Size by Region

8.3.1 Asia-Pacific COVID-19 Diagnosis Revenue by Region (2016-2026)

8.3.2 China COVID-19 Diagnosis Market Size and Forecast (2016-2026)

8.3.3 Japan COVID-19 Diagnosis Market Size and Forecast (2016-2026)

8.3.4 South Korea COVID-19 Diagnosis Market Size and Forecast (2016-2026)

8.3.5 India COVID-19 Diagnosis Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia COVID-19 Diagnosis Market Size and Forecast (2016-2026)

8.3.7 Australia COVID-19 Diagnosis Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America COVID-19 Diagnosis Revenue by Type (2016-2026)

9.2 South America COVID-19 Diagnosis Revenue by Application (2016-2026)

9.3 South America COVID-19 Diagnosis Market Size by Country

9.3.1 South America COVID-19 Diagnosis Revenue by Country (2016-2026)

9.3.2 Brazil COVID-19 Diagnosis Market Size and Forecast (2016-2026)

9.3.3 Argentina COVID-19 Diagnosis Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa COVID-19 Diagnosis Revenue by Type (2016-2026)

10.2 Middle East & Africa COVID-19 Diagnosis Revenue by Application (2016-2026)

10.3 Middle East & Africa COVID-19 Diagnosis Market Size by Country

10.3.1 Middle East & Africa COVID-19 Diagnosis Revenue by Country (2016-2026)

10.3.2 Turkey COVID-19 Diagnosis Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia COVID-19 Diagnosis Market Size and Forecast (2016-2026)

10.3.4 UAE COVID-19 Diagnosis Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global COVID-19 Diagnosis Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global COVID-19 Diagnosis Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market COVID-19 Diagnosis Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global COVID-19 Diagnosis Revenue (USD Million) by Region (2016-2021)

Table 5. Global COVID-19 Diagnosis Revenue Market Share by Region (2021-2026)

Table 6. Cepheid Corporate Information, Head Office, and Major Competitors

Table 7. Cepheid Major Business

Table 8. Cepheid COVID-19 Diagnosis Product and Solutions

Table 9. Cepheid COVID-19 Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Abbott Corporate Information, Head Office, and Major Competitors

Table 11. Abbott Major Business

Table 12. Abbott COVID-19 Diagnosis Product and Solutions

Table 13. Abbott COVID-19 Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Mesa Biotech Corporate Information, Head Office, and Major Competitors

Table 15. Mesa Biotech Major Business

Table 16. Mesa Biotech COVID-19 Diagnosis Product and Solutions

Table 17. Mesa Biotech COVID-19 Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Microsens Dx Corporate Information, Head Office, and Major Competitors

Table 19. Microsens Dx Major Business

Table 20. Microsens Dx COVID-19 Diagnosis Product and Solutions

Table 21. Microsens Dx COVID-19 Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. GenMark Diagnostics Corporate Information, Head Office, and Major Competitors

Table 23. GenMark Diagnostics Major Business

Table 24. GenMark Diagnostics COVID-19 Diagnosis Product and Solutions

Table 25. GenMark Diagnostics COVID-19 Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Credo Corporate Information, Head Office, and Major Competitors

Table 27. Credo Major Business

Table 28. Credo COVID-19 Diagnosis Product and Solutions

Table 29. Credo COVID-19 Diagnosis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Global COVID-19 Diagnosis Revenue (USD Million) by Players (2019-2021)

Table 31. Global COVID-19 Diagnosis Revenue Share by Players (2019-2021)

Table 32. Breakdown of COVID-19 Diagnosis by Company Type (Tier 1, Tier 2 and Tier 3)

Table 33. COVID-19 Diagnosis Players Head Office, Products and Services Provided

Table 34. COVID-19 Diagnosis Mergers & Acquisitions in the Past Five Years

Table 35. COVID-19 Diagnosis New Entrants and Expansion Plans

Table 36. Global COVID-19 Diagnosis Revenue (USD Million) by Type (2016-2021)

Table 37. Global COVID-19 Diagnosis Revenue Share by Type (2016-2021)

Table 38. Global COVID-19 Diagnosis Revenue Forecast by Type (2021-2026)

Table 39. Global COVID-19 Diagnosis Revenue by Application (2016-2021)

Table 40. Global COVID-19 Diagnosis Revenue Forecast by Application (2021-2026)

Table 41. North America COVID-19 Diagnosis Revenue by Type (2016-2021) & (USD Million)

Table 42. North America COVID-19 Diagnosis Revenue by Type (2021-2026) & (USD Million)

Table 43. North America COVID-19 Diagnosis Revenue by Application (2016-2021) & (USD Million)

Table 44. North America COVID-19 Diagnosis Revenue by Application (2021-2026) & (USD Million)

Table 45. North America COVID-19 Diagnosis Revenue by Country (2016-2021) & (USD Million)

Table 46. North America COVID-19 Diagnosis Revenue by Country (2021-2026) & (USD Million)

Table 47. Europe COVID-19 Diagnosis Revenue by Type (2016-2021) & (USD Million)

Table 48. Europe COVID-19 Diagnosis Revenue by Type (2021-2026) & (USD Million)

Table 49. Europe COVID-19 Diagnosis Revenue by Application (2016-2021) & (USD Million)

Table 50. Europe COVID-19 Diagnosis Revenue by Application (2021-2026) & (USD Million)

Table 51. Europe COVID-19 Diagnosis Revenue by Country (2016-2021) & (USD Million)

Table 52. Europe COVID-19 Diagnosis Revenue by Country (2021-2026) & (USD Million)

Table 53. Asia-Pacific COVID-19 Diagnosis Revenue by Type (2016-2021) & (USD Million)

Table 54. Asia-Pacific COVID-19 Diagnosis Revenue by Type (2021-2026) & (USD Million)

Table 55. Asia-Pacific COVID-19 Diagnosis Revenue by Application (2016-2021) & (USD Million)

Table 56. Asia-Pacific COVID-19 Diagnosis Revenue by Application (2021-2026) & (USD Million)

Table 57. Asia-Pacific COVID-19 Diagnosis Revenue by Region (2016-2021) & (USD Million)

Table 58. Asia-Pacific COVID-19 Diagnosis Revenue by Region (2021-2026) & (USD Million)

Table 59. South America COVID-19 Diagnosis Revenue by Type (2016-2021) & (USD Million)

Table 60. South America COVID-19 Diagnosis Revenue by Type (2021-2026) & (USD Million)

Table 61. South America COVID-19 Diagnosis Revenue by Application (2016-2021) & (USD Million)

Table 62. South America COVID-19 Diagnosis Revenue by Application (2021-2026) & (USD Million)

Table 63. South America COVID-19 Diagnosis Revenue by Country (2016-2021) & (USD Million)

Table 64. South America COVID-19 Diagnosis Revenue by Country (2021-2026) & (USD Million)

Table 65. Middle East & Africa COVID-19 Diagnosis Revenue by Type (2016-2021) & (USD Million)

Table 66. Middle East & Africa COVID-19 Diagnosis Revenue by Type (2021-2026) & (USD Million)

Table 67. Middle East & Africa COVID-19 Diagnosis Revenue by Application (2016-2021) & (USD Million)

Table 68. Middle East & Africa COVID-19 Diagnosis Revenue by Application (2021-2026) & (USD Million)

Table 69. Middle East & Africa COVID-19 Diagnosis Revenue by Country (2016-2021) & (USD Million)

Table 70. Middle East & Africa COVID-19 Diagnosis Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. COVID-19 Diagnosis Picture

Figure 2. Global COVID-19 Diagnosis Revenue Market Share by Type in 2020

Figure 3. RT-PCR

Figure 4. Isothermal Nucleic Acid Amplification

Figure 5. Others

Figure 6. COVID-19 Diagnosis Revenue Market Share by Application in 2020

Figure 7. Hospital Picture

Figure 8. Laboratory Picture

Figure 9. Global COVID-19 Diagnosis Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global COVID-19 Diagnosis Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global COVID-19 Diagnosis Revenue Market Share by Region (2016-2026)

Figure 12. Global COVID-19 Diagnosis Revenue Market Share by Region in 2020

Figure 13. North America COVID-19 Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe COVID-19 Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific COVID-19 Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America COVID-19 Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa COVID-19 Diagnosis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. COVID-19 Diagnosis Market Drivers

Figure 19. COVID-19 Diagnosis Market Restraints

Figure 20. COVID-19 Diagnosis Market Trends

Figure 21. Cepheid Recent Developments and Future Plans

Figure 22. Abbott Recent Developments and Future Plans

Figure 23. Mesa Biotech Recent Developments and Future Plans

Figure 24. Microsens Dx Recent Developments and Future Plans

Figure 25. GenMark Diagnostics Recent Developments and Future Plans

Figure 26. Credo Recent Developments and Future Plans

Figure 27. Global COVID-19 Diagnosis Revenue Share by Players in 2020

Figure 28. COVID-19 Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 29. Global Top 3 Players COVID-19 Diagnosis Revenue Market Share in 2020

Figure 30. Global Top 10 Players COVID-19 Diagnosis Revenue Market Share in 2020

Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 32. Global COVID-19 Diagnosis Revenue Share by Type in 2020

Figure 33. Global COVID-19 Diagnosis Market Share Forecast by Type (2021-2026)

Figure 34. Global COVID-19 Diagnosis Revenue Share by Application in 2020

Figure 35. Global COVID-19 Diagnosis Market Share Forecast by Application (2021-2026)

Figure 36. North America COVID-19 Diagnosis Sales Market Share by Type (2016-2026)

Figure 37. North America COVID-19 Diagnosis Sales Market Share by Application (2016-2026)

Figure 38. North America COVID-19 Diagnosis Revenue Market Share by Country (2016-2026)

Figure 39. United States COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 40. Canada COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Mexico COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Europe COVID-19 Diagnosis Sales Market Share by Type (2016-2026)

Figure 43. Europe COVID-19 Diagnosis Sales Market Share by Application (2016-2026)

Figure 44. Europe COVID-19 Diagnosis Revenue Market Share by Country (2016-2026)

Figure 45. Germany COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. France COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. United Kingdom COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Russia COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Italy COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Asia-Pacific COVID-19 Diagnosis Sales Market Share by Type (2016-2026)

Figure 51. Asia-Pacific COVID-19 Diagnosis Sales Market Share by Application (2016-2026)

Figure 52. Asia-Pacific COVID-19 Diagnosis Revenue Market Share by Region (2016-2026)

Figure 53. China COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Japan COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. South Korea COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. India COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Southeast Asia COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Australia COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. South America COVID-19 Diagnosis Sales Market Share by Type (2016-2026)

Figure 60. South America COVID-19 Diagnosis Sales Market Share by Application (2016-2026)

Figure 61. South America COVID-19 Diagnosis Revenue Market Share by Country (2016-2026)

Figure 62. Brazil COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Argentina COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Middle East and Africa COVID-19 Diagnosis Sales Market Share by Type (2016-2026)

Figure 65. Middle East and Africa COVID-19 Diagnosis Sales Market Share by Application (2016-2026)

Figure 66. Middle East and Africa COVID-19 Diagnosis Revenue Market Share by Country (2016-2026)

Figure 67. Turkey COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Saudi Arabia COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. UAE COVID-19 Diagnosis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Methodology

Figure 71. Research Process and Data Source